124 related articles for article (PubMed ID: 27369187)
1. Hypercalcemic crisis associated with anastrozole use in a patient with breast cancer and primary hyperparathyroidism.
Yu R
Endocrine; 2016 Sep; 53(3):868-9. PubMed ID: 27369187
[No Abstract] [Full Text] [Related]
2. Anastrozole can cause severe hypercalcaemia mimicking primary hyperparathyroidism.
Järhult J
Breast Cancer; 2014 May; 21(3):379-81. PubMed ID: 21290264
[TBL] [Abstract][Full Text] [Related]
3. Hemicentral retinal artery occlusion in a breast cancer patient using anastrozole.
Karagöz B; Ayata A; Bilgi O; Uzun G; Unal M; Kandemir EG; Ozgün A; Türken O
Onkologie; 2009 Jul; 32(7):421-3. PubMed ID: 19556821
[TBL] [Abstract][Full Text] [Related]
4. World's largest breast cancer treatment trial supports anastrozole use.
Oncology (Williston Park); 2002 Jan; 16(1):63. PubMed ID: 11831610
[No Abstract] [Full Text] [Related]
5. Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
Margolese RG; Cecchini RS; Julian TB; Ganz PA; Costantino JP; Vallow LA; Albain KS; Whitworth PW; Cianfrocca ME; Brufsky AM; Gross HM; Soori GS; Hopkins JO; Fehrenbacher L; Sturtz K; Wozniak TF; Seay TE; Mamounas EP; Wolmark N
Lancet; 2016 Feb; 387(10021):849-56. PubMed ID: 26686957
[TBL] [Abstract][Full Text] [Related]
6. Case 24-2005: a woman with estrogen-receptor-positive breast cancer.
Denes AE
N Engl J Med; 2005 Nov; 353(21):2304-5; author reply 2304-5. PubMed ID: 16306534
[No Abstract] [Full Text] [Related]
7. Anastrozole-induced hepatotoxicity.
Zapata E; Zubiaurre L; Bujanda L; Piérola A
Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1233-4. PubMed ID: 17033446
[TBL] [Abstract][Full Text] [Related]
8. Successful desensitisation to Anastrozole.
Rodrigues J; Malheiro D; Botelho C; Cruz MC; Castel-Branco MG
Allergol Immunopathol (Madr); 2009; 37(1):50-1. PubMed ID: 19268063
[No Abstract] [Full Text] [Related]
9. Anastrozole: brain draining or sparing?
Berga SL
Lancet Oncol; 2008 Oct; 9(10):913-4. PubMed ID: 19071243
[No Abstract] [Full Text] [Related]
10. [Campaign against breast cancer. Are aromatase inhibitors the better choice? (interview by Dr. Dorothea Dlugosch)].
Bruntsch U
MMW Fortschr Med; 2002 Sep; 144(38):20. PubMed ID: 12395697
[No Abstract] [Full Text] [Related]
11. Metastasis of lobular breast carcinoma to the uterus in a patient under anastrozole therapy.
Ustaalioglu BB; Bilici A; Seker M; Salman T; Gumus M; Barisik NO; Salepci T; Yaylaci M
Onkologie; 2009 Jul; 32(7):424-6. PubMed ID: 19556822
[TBL] [Abstract][Full Text] [Related]
12. Tardive dyskinesia associated with anastrozole.
Manjunatha N; Ganjekar S; Mahendra JV; Kilara N; Srinivasa R
J Neuropsychiatry Clin Neurosci; 2013; 25(3):E27-8. PubMed ID: 24026733
[No Abstract] [Full Text] [Related]
13. Experience of hormonal therapy with anastrozole for previously treated metastatic breast cancer.
Lavrenkov K; Man S; Geffen DB; Cohen Y
Isr Med Assoc J; 2002 Mar; 4(3):176-7. PubMed ID: 11908256
[TBL] [Abstract][Full Text] [Related]
14. Uterine and quality of life changes in postmenopausal women with an asymptomatic tamoxifen-thickened endometrium randomized to continuation of tamoxifen or switching to anastrozole.
Van Calster B; Van Ginderachter J; Vlasselaer J; Van de Putte G; Berteloot P; Timmerman D; Depypere H; Blomme C; Vlaemynck G; De Jonge E; Van den Broecke R; Vergote I; Amant F; Van Huffel S; Neven P
Menopause; 2011 Feb; 18(2):224-9. PubMed ID: 20881891
[TBL] [Abstract][Full Text] [Related]
15. A lower incidence of gynecologic adverse events and interventions with anastrozole than with tamoxifen in the ATAC trial.
Duffy SR; Distler W; Howell A; Cuzick J; Baum M
Am J Obstet Gynecol; 2009 Jan; 200(1):80.e1-7. PubMed ID: 19019322
[TBL] [Abstract][Full Text] [Related]
16. Hypercalcemic crisis in the era of targeted parathyroidectomy.
Beck W; Lew JI; Solórzano CC
J Surg Res; 2011 Dec; 171(2):404-8. PubMed ID: 21658721
[TBL] [Abstract][Full Text] [Related]
17. Fulvestrant 250 mg versus anastrozole for Chinese patients with advanced breast cancer: results of a multicentre, double-blind, randomised phase III trial.
Xu B; Jiang Z; Shao Z; Wang J; Feng J; Song S; Chen Z; Gu K; Yu S; Zhang Y; Wang C; Zhang F; Yang J
Cancer Chemother Pharmacol; 2011 Jan; 67(1):223-30. PubMed ID: 20938664
[TBL] [Abstract][Full Text] [Related]
18. Changes in endocrine therapy: anastrozole and advanced breast cancer in postmenopausal women.
Nabholtz JM
Am J Hosp Palliat Care; 2004; 21(6):457-65. PubMed ID: 15612238
[TBL] [Abstract][Full Text] [Related]
19. Anastrozole for breast cancer: recent advances and ongoing challenges.
Buzdar AU
Expert Rev Anticancer Ther; 2006 Jun; 6(6):839-48. PubMed ID: 16761927
[TBL] [Abstract][Full Text] [Related]
20. Anastrozole: licence extension. No advantage over tamoxifen in advanced-stage breast cancer.
Prescrire Int; 2001 Jun; 10(53):76-7. PubMed ID: 11718168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
